|
|
40
|
|
|
1133FV
|
|
|
LIPITAS 40MG TAB (INP/AHI) ATORVASTATIN
|
|
|
ATORVASTATIN
|
|
|
LIPITAS
|
|
|
30'S
|
|
|
A
|
|
|
5.41
|
|
|
0.1803
|
|
|
40MG
|
|
|
TABLET IMMED
|
|
|
30
|
|
|
|
|
|
INP
|
|
|
INTAS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2023-03-20
|
|
|
2024-03-31
|
|
|
No
|
|
|
No
|
|
|
1TOD
|
|
|
1
|
|
|
N
|
|
|
240608
|
|
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
Add to Contract as Cat A
|
|
|
Oral
|
|
|
6
|
|
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
2023-01-04
|